Abstract
The authors report their experience on the use of 111In-DTPA-octreotide scintigraphy in the diagnosis of neuroendocrine carcinomas of the lung. The studies were performed both preoperatively, to obtain a correct staging of the tumor, or postoperatively, because of the suspicion of a recurrence or distant metastases. The main findings were: high sensitivity in localizing the tumor and its recurrences or metastases and high predictive value for responsiveness to "cold" octreotide therapy.
Original language | English |
---|---|
Pages (from-to) | 653-656 |
Number of pages | 4 |
Journal | Journal of Cardiovascular Surgery |
Volume | 37 |
Issue number | 6 |
Publication status | Published - Dec 1996 |
Externally published | Yes |
Keywords
- Carcinoma, neuroendocrine
- Lung neoplasms
- Lung radionuclide imaging
- Neuroendocrine tumors
- Octreotide diagnostic use